Detailed Information on Publication Record
2022
Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?
GALUŠKA, David, Lucie DLOUHÁ, Jaroslav HUBÁČEK and Kateřina KAŇKOVÁBasic information
Original name
Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?
Authors
GALUŠKA, David (203 Czech Republic, belonging to the institution), Lucie DLOUHÁ (203 Czech Republic, guarantor), Jaroslav HUBÁČEK (203 Czech Republic) and Kateřina KAŇKOVÁ (203 Czech Republic, belonging to the institution)
Edition
FOLIA BIOLOGICA, PRAGUE, CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINE, 2022, 0015-5500
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30101 Human genetics
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 0.600
RIV identification code
RIV/00216224:14110/22:00134644
Organization unit
Faculty of Medicine
UT WoS
001010557100001
Keywords in English
diabetes mellitus; diabetes complication; polymorphism; Central European population; genetic; GWAS; diabetic neuropathy; diabetic kidney disease; diabetic retinopathy; cardiovascular disease
Tags
International impact, Reviewed
Změněno: 9/8/2023 12:06, Mgr. Tereza Miškechová
Abstract
V originále
Type 2 diabetes mellitus (T2DM) is a com-plex disease that has risen in global prevalence over recent decades, resulting in concomitant and enor-mous socio-economic impacts. In addition to the well-documented risk factors of obesity, poor dietary habits and sedentary lifestyles, genetic background plays a key role in the aetiopathogenesis of diabetes and the development of associated micro-and macro -vascular complications. Recent advances in genomic research, notably next-generation sequencing and ge-nome-wide association studies, have greatly improved the efficiency with which genetic backgrounds to com-plex diseases are analysed. To date, several hundred single-nucleotide polymorphisms have been associ-ated with T2DM or its complications. Given the poly -genic background to T2DM (and numerous other complex diseases), the degree of genetic predisposi-tion can be treated as a "continuous trait" quantified by a genetic risk score. Focusing mainly on the Central European population, this review summa-rizes recent state-of-the-art methods that have en-abled us to better determine the genetic architecture of T2DM and the utility of genetic risk scores in dis-ease prediction.
Links
NV18-01-00046, research and development project |
|